Clinical Trial Update: Propranolol for Aggression, Self-Injury, and Severe Disruptive Behavior in Adolescents and Adults With Autism [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating propranolol to reduce aggression, self-injury, and severe disruptive behavior in adolescents and adults with autism; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Propranolol (propranolol)

Snippet

Sponsor: Jeremy Veenstra-vanderweele | Conditions: Autism Spectrum Disorder, Challenging Behaviour | Phase 2 | Status: RECRUITING